We are live on ! Find out more
Hudson Bay Capital Management

Hudson Bay Capital Management Portfolio holdings

AUM $29B
1-Year Est. Return 30.2%
This Fund
S&P 500
This Quarter Est. Return
+3.44%
1 Year Est. Return
+30.2%
3 Year Est. Return
+99.99%
5 Year Est. Return
+135.78%
10 Year Est. Return
+498.47%
AUM
$4.36B
AUM Growth
-$3.4B
Cap. Flow
-$4.63B
Cap. Flow %
-106.13%
Top 10 Hldgs %
37.55%
Holding
816
New
146
Increased
76
Reduced
85
Closed
414

Sector Composition

Rank Sector Weight
1 Healthcare 10.54%
2 Communication Services 8.17%
3 Technology 7.58%
4 Financials 3.93%
5 Consumer Discretionary 3.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTC icon
251
PTC
PTC
$16B
$2.06M 0.05%
+23,000
New +$2.06M
INSUU
252
DELISTED
Insurance Acquisition Corp. Unit
INSUU
$2.06M 0.05%
200,000
CENT icon
253
CALL
Central Garden & Pet Co
CENT
$2.8B
$2.02M 0.05%
93,750
DEACU
254
DELISTED
Diamond Eagle Acquisition Corp. Unit
DEACU
$2.01M 0.05%
+200,000
New +$2.01M
CARM
255
DELISTED
Carisma Therapeutics
CARM
$1.96M 0.05%
+65,318
New +$1.96M
MSGS icon
256
Madison Square Garden
MSGS
$9.39B
$1.96M 0.05%
9,814
-17,260
-64% -$3.68M
GLACU
257
DELISTED
Greenland Acquisition Corporation Unit
GLACU
$1.95M 0.04%
185,000
DDMXU
258
DELISTED
DD3 Acquisition Corp. Units
DDMXU
$1.95M 0.04%
190,000
PVH icon
259
PVH
PVH
$4.04B
$1.89M 0.04%
+20,000
New +$2.21M
AKCA
260
DELISTED
Akcea Therapeutics Inc
AKCA
$1.88M 0.04%
80,000
+40,000
+100% +$988K
CNDT icon
261
Conduent
CNDT
$264M
$1.87M 0.04%
+195,305
New +$2.11M
TOTAU
262
DELISTED
Tottenham Acquisition I Limited Unit
TOTAU
$1.87M 0.04%
180,000
ABUS icon
263
Arbutus Biopharma
ABUS
$915M
$1.84M 0.04%
885,000
+235,000
+36% +$601K
TIBRU
264
DELISTED
Tiberius Acquisition Corporation Units
TIBRU
$1.84M 0.04%
175,000
SAGE
265
DELISTED
Sage Therapeutics
SAGE
$1.83M 0.04%
10,000
-10,000
-50% -$1.71M
SRNE
266
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$1.77M 0.04%
+662,059
New +$2.38M
QCOM icon
267
CALL
Qualcomm
QCOM
$176B
$1.76M 0.04%
+23,100
New +$1.69M
BIIB icon
268
Biogen
BIIB
$30.7B
$1.75M 0.04%
7,500
-26,300
-78% -$6.07M
GE icon
269
GE Aerospace
GE
$384B
$1.73M 0.04%
33,105
+8,989
+37% +$442K
HALO icon
270
CALL
Halozyme
HALO
$12.2B
$1.72M 0.04%
+100,000
New +$1.61M
ALKS icon
271
Alkermes
ALKS
$8.25B
$1.69M 0.04%
+75,000
New +$2.06M
PTLA
272
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.63M 0.04%
60,000
-2,500
-4% -$78.4K
ATVI
273
DELISTED
Activision Blizzard
ATVI
$1.6M 0.04%
34,000
-41,215
-55% -$1.89M
CASY icon
274
Casey's General Stores
CASY
$30.9B
$1.56M 0.04%
+10,000
New +$1.36M
KNSA icon
275
Kiniksa Pharmaceuticals
KNSA
$5.93B
$1.56M 0.04%
115,000
+25,000
+28% +$388K

Similar funds

Hudson Bay Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Hudson Bay Capital Management held 816 positions worth $4.36B, down 44% from $7.76B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Hudson Bay Capital Management withdrew a net $4.63B in Q2 2019, closing 414 positions and reducing 85 holdings. Its most notable exit was Chubb, an estimated $25.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 4.7% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Hudson Bay Capital Management opened a new position in Boston Scientific worth $36.5M.

  • Hudson Bay Capital Management's largest Q2 2019 buy was Boston Scientific: 850,000 shares worth $36.5M.
  • Hudson Bay Capital Management added most to Altaba Inc in Q2 2019, an estimated $84.7M increase.
  • Hudson Bay Capital Management's biggest Q2 2019 reduction was Liberty Expedia Holdings, Inc. Class A Common Stock, cutting an estimated $78.6M.
  • Hudson Bay Capital Management fully exited Chubb in Q2 2019, selling an estimated $25.9M.
  • Hudson Bay Capital Management's ten largest holdings make up 38% of its $4.36B portfolio in Q2 2019.
  • Hudson Bay Capital Management opened 146 new positions and closed 414 in Q2 2019.
  • Hudson Bay Capital Management's portfolio value fell 44% quarter-over-quarter to $4.36B.

Based on Hudson Bay Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.